Rare Disease Advisor

@rarediseaseadvisor.bsky.social

Trusted knowledge base of practical information and resources focused on treating and diagnosing #RareDisease. https://www.rarediseaseadvisor.com/

#AIHA is highly prevalent in patients with #SLE, and some studies report poorer outcomes in patients with both conditions. Taken together, these findings underscore the importance of early detection of SLE-associated AIHA. Read more: https://bit.ly/4c9fgVh #RareDisease #MedSky

Early Autoimmune Signals: The Role of AIHA in Identifying SLE

An autoimmune disease, AIHA is considered one of the most frequent hematologic manifestations of SLE, also an autoimmune condition.

bit.ly

🎙️ An important conversation on #BeckerMuscularDystrophy Larry Luxner sits down with Abby Bronson, VP of Patient Advocacy at Edgewise Therapeutics, to discuss efforts to raise awareness of #Becker muscular dystrophy as distinct from #Duchenne muscular dystrophy 🎧 Listen here: https://bit.ly/4tBOeNv

An Interview With Abby Bronson of Edgewise Therapeutics About Becker Muscular Dystrophy Awareness

Abby Bronson advocates for those with Becker muscular dystrophy, which can have severe consequences on mobility and quality of life.

bit.ly

Exon-skipping offers a highly targeted and transformative approach to treating Duchenne muscular dystrophy (#DMD). These therapies work by restoring the reading frame of the DMD gene, enabling #Dystrophin synthesis. Read here: https://bit.ly/4vjwaJK #RareDisease #MedSky

Exon-Skipping in DMD: From Mechanisms to Clinical Practice

In Duchenne muscular dystrophy (DMD), exon-skipping therapy has transformed from an experimental approach to an established treatment.

bit.ly

Results from a phase 1/2a trial showed intravenous human umbilical cord-derived mesenchymal stromal cell (hUC-MSC) therapy may reduce disease activity and neurological impairment in neuromyelitis optica spectrum disorder (#NMOSD). Learn more: https://bit.ly/3PO79Gt #RareDisease #MedSky

Mesenchymal Stromal Cell Therapy Reduces Relapse Rate and Lesion Burden in NMOSD

Intravenous infusion of mesenchymal stromal cells derived from umbilical tissue appears safe, with early evidence of effectiveness in NMOSD.

bit.ly

🌟 Rare Advocacy Spotlight: Genetic Alliance Highlighting programs like #iHope, the Genetic Alliance Biobank (GAB), and the “Does it Run in the Family?” toolkit - advancing access to genomic medicine. 🔗 Read more: https://bit.ly/3O6HaJL #RareAdvocacySpotlight #GeneticAlliance #iHope #MedSky

Rare Advocacy Spotlight: Genetic Alliance

Discover how the Genetic Alliance is transforming healthcare and supporting families with rare disease programs.

bit.ly

The levels of apurinic/apyrimidinic endodeoxyribonuclease 1 (#APEX1) in the serum could be used as a diagnostic biomarker in cholangiocarcinoma (#CCA) and hepatocellular carcinoma (#HCC). Study in the Egyptian Liver Journal. Read more: https://bit.ly/4truf3S #RareDisease #MedSky #OncSky

APEX1 Could Be a Novel Biomarker for CCA and HCC

The levels of APEX1 in the serum could be used as a diagnostic biomarker in cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC), research shows.

bit.ly